GIA
ARKG icon

Gladstone Institutional Advisory’s ARK Genomic Revolution ETF ARKG Stock Holding History

Gladstone Institutional Advisory’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-8,972
Closed -$258K – 662
2024
Q1 		$258K Sell
8,972
-2,475
-22% -$74.4K 0.01% 562
2023
Q4 		$376K Sell
11,447
-7,092
-38% -$193K 0.02% 476
2023
Q3 		$516K Sell
18,539
-2,434
-12% -$79.6K 0.03% 381
2023
Q2 		$715K Sell
20,973
-3,355
-14% -$105K 0.04% 336
2023
Q1 		$732K Sell
24,328
-3,180
-12% -$98.5K 0.05% 340
2022
Q4 		$777K Sell
27,508
-1,349
-5% -$42.8K 0.05% 320
2022
Q3 		$949K Sell
28,857
-3,830
-12% -$141K 0.07% 276
2022
Q2 		$1.03M Sell
32,687
-1,546
-5% -$54.1K 0.08% 263
2022
Q1 		$1.57M Sell
34,233
-64,425
-65% -$3.07M 0.11% 215
2021
Q4 		$6.04M Sell
98,658
-14,949
-13% -$1.03M 0.47% 49
2021
Q3 		$8.49M Sell
113,607
-33,962
-23% -$2.85M 0.83% 20
2021
Q2 		$13.7M Sell
147,569
-11,620
-7% -$988K 1.62% 6
2021
Q1 		$14.1M Buy
159,189
+31,997
+25% +$3.17M 2.2% 4
2020
Q4 		$11.9M Buy
127,192
+109,845
+633% +$8.75M 2.36% 5
2020
Q3 		$1.1M Buy
17,347
+12,488
+257% +$732K 0.26% 84
2020
Q2 		$253K Sell
4,859
-3,891
-44% -$167K 0.06% 193
2020
Q1 		$274K Buy
8,750
+966
+12% +$32.3K 0.07% 202
2019
Q4 		$261K Buy
+7,784
New +$247K 0.06% 211

Other funds holding ARKG

MMEA
Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Gladstone Institutional Advisory's ARKG Position: Q2 2024 in Review

Gladstone Institutional Advisory sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2024, closing a stake of 8,972 shares — an estimated $258K sold.

Gladstone Institutional Advisory first reported a position in ARKG in Q4 2019 and held it in 18 quarters. The position peaked at $14.1M in Q1 2021. 261 funds tracked by Wall St. Rank hold ARKG as of Q2 2024.

  • Gladstone Institutional Advisory reported no remaining ARK Genomic Revolution ETF position as of Q2 2024 after selling out during the quarter.
  • Gladstone Institutional Advisory sold 8,972 ARK Genomic Revolution ETF shares in Q2 2024, an estimated $258K.
  • Gladstone Institutional Advisory first reported a position in ARK Genomic Revolution ETF in Q4 2019 and held it in 18 quarters.
  • Gladstone Institutional Advisory's ARK Genomic Revolution ETF position peaked at $14.1M in Q1 2021.
  • 261 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2024.

Based on Gladstone Institutional Advisory's 13F filing for Q2 2024, filed 2 Aug 2024.